Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Intracranial arterial lumen" refers to the hollow passage inside arteries located within the cranial cavity, through which blood flows to supply the brain[1][2][3]. This is an anatomical structure, not a molecule, receptor, or protein, and does not conform to the usual concept of a drug target such as a receptor or enzyme. The intracranial arterial lumen is the space inside the arteries of the brain, such as the internal carotid arteries, vertebral arteries, middle cerebral arteries, and parts of the circle of Willis[3][4]. It is lined by endothelium, surrounded by smooth muscle (tunica media), and elastic membranes, comprising the arterial wall architecture[1][2]. The lumen's diameter is dynamically regulated, affecting cerebral blood flow, perfusion, and intracranial pressure, and is central to stroke, aneurysm, and vascular malformation pathophysiology[2][3][4]. In summary, the "intracranial arterial lumen" is an anatomical space inside brain arteries that carries blood to the brain. It is not a molecule or canonical receptor, so it should not be classified as a therapeutic molecular target. Interventions may act on its diameter or patency but do so via the tissues forming its walls or their molecular components, not the lumen itself[1][2][3][4].
Vasodilation of arterial smooth muscle increases lumen diameter (e.g., via nitric oxide, calcium channel blockers) Antithrombotic effects prevent lumen occlusion Anti-atherosclerotic agents improve arterial lumen patency
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracranial arterial lumen.